A5103044643- Extracellular vesicles in disease
- Nanoplatforms for cancer theranostics
- Lung Cancer Research Studies
- MicroRNA in disease regulation
- Pulmonary Hypertension Research and Treatments
- Hydrogen's biological and therapeutic effects
- thermodynamics and calorimetric analyses
- Solar-Powered Water Purification Methods
- Cancer Immunotherapy and Biomarkers
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Immune cells in cancer
- Advanced Nanomaterials in Catalysis
- Respiratory Support and Mechanisms
- Curcumin's Biomedical Applications
- Inhalation and Respiratory Drug Delivery
Second Military Medical University
2023-2024
Abstract Acute lung injury (ALI) is a severe respiratory disease with high mortality rate. The integrity of the pulmonary endothelial barrier influences development and prognosis ALI. Therefore, it has become an important target for ALI treatment. Extracellular vesicles (EVs) are promising nanotherapeutic agents against Herein, endothelium‐derived engineered extracellular (eEVs) that deliver microRNA‐125b‐5p (miRNA‐125b) to tissues exerting protective effect on reported. eEVs modified...
Extracellular vesicles (EVs) are lipid bilayer nanoparticles naturally released from cells, playing a crucial role in intercellular communication. They modulate gene expression and regulate physiological pathological processes, including acute lung injury (ALI) respiratory distress syndrome (ARDS). Research has shown that EVs contain variety of active components, biocompatible small size, do not trigger immune rejection, making the infusion exogenous promising therapeutic tool. With further...